GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Glenmark Life Sciences Ltd (BOM:543322) » Definitions » Total Long-Term Liabilities

Glenmark Life Sciences (BOM:543322) Total Long-Term Liabilities : ₹826 Mil (As of Sep. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Glenmark Life Sciences Total Long-Term Liabilities?

Total Long-Term Liabilities includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities. Glenmark Life Sciences's Total Long-Term Liabilities for the quarter that ended in Sep. 2024 was ₹826 Mil.


Glenmark Life Sciences Total Long-Term Liabilities Historical Data

The historical data trend for Glenmark Life Sciences's Total Long-Term Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Glenmark Life Sciences Total Long-Term Liabilities Chart

Glenmark Life Sciences Annual Data
Trend Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Total Long-Term Liabilities
Get a 7-Day Free Trial 164.48 228.88 326.99 673.96 793.17

Glenmark Life Sciences Quarterly Data
Mar19 Mar20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Total Long-Term Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 622.37 - 793.17 - 826.45

Glenmark Life Sciences Total Long-Term Liabilities Calculation

Total Long-Term Liabilities represents the obiligation that incurred as part of normal operations that is expected to be repaid beyond the following twelve months or one business cycle, excluding minority interest. It includes Long-Term Debt & Capital Lease Obligation, PensionAndRetirementBenefit, NonCurrent Deferred Liabilities and Other Long-Term Liabilities.


Glenmark Life Sciences Total Long-Term Liabilities Related Terms

Thank you for viewing the detailed overview of Glenmark Life Sciences's Total Long-Term Liabilities provided by GuruFocus.com. Please click on the following links to see related term pages.


Glenmark Life Sciences Business Description

Traded in Other Exchanges
Address
470, Cardinal Gracious Road, 4th Floor, OIA House, Andheri (East), Mumbai, MH, IND, 400099
Glenmark Life Sciences Ltd develops, manufactures, and supplies high-quality active pharmaceutical ingredients for cardiovascular disease, central nervous system disease, pain management, and diabetes, gastrointestinal disorders, anti-infectives, and other therapeutic areas.

Glenmark Life Sciences Headlines

No Headlines